Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Demir Firat, A. Merzi Ozturk, T. Kaya, D. Karnak, O. Kayacan (Ankara, Turkey). What is the role of hypoxaemia, 6-minute walk test, diffusion capacity, pulmonary arterial hypertension in diffuse interstitial lung diseases?. Eur Respir J 2009; 34: Suppl. 53, 728

Member's Comments

No comment yet.

Related content which might interest you: The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 25: 96-103 Year: 2005 6-minute walk test predicts pulmonary artery pressure in patients with collagen vascular disease associated interstitial pneumonia Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension Source: Eur Respir J 2012; 40: 1410-1419 Year: 2012 Sex differences in physiological progression of idiopathic pulmonary fibrosis Source: Eur Respir J 2008; 31: 1183-1188 Year: 2008 Exercise testing in pulmonary arterial hypertension and in chronic heart failure Source: Eur Respir J 2004; 23: 747-751 Year: 2004 The effect of moderate altitude on pulmonary function tests, CO diffusion capacity, blood gases and QT dispersion in elderly patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 417s Year: 2001 Clinical predictors of pulmonary hypertension in sarcoidosis Source: Eur Respir J 2008; 32: 296-302 Year: 2008 The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension Source: Eur Respir J 2010; 36: 1294-1301 Year: 2010 Patterns of cardiopulmonary response to exercise in lung diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-49-5, page=69 Year: 2007 Comparability of shuttle walk test with 6-minutes walk test in pulmonary diseases with emphasis on pulmonary arterial hypertension Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases Year: 2013 Predictive factors of developing exercise pulmonary arterial hypertension in emphysematous patients with mild hypoxemia at rest Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange Year: 2005 Pulmonary vascular response patterns during exercise in interstitial lung disease (ILD) Source: International Congress 2014 – Mechanisms of exercise limitation in disease Year: 2014 A step test to assess exercise-related oxygen desaturation in interstitial lung disease Source: Eur Respir J 2007; 29: 330-336 Year: 2007 Effect of ambulatory oxygen on walking distance in normoxic pulmonary fibrosis Source: Annual Congress 2006 - Pulmonary fibrosis: pathophysiology and therapeutic approaches Year: 2006 Challenges in idiopathic pulmonary fibrosis trials: the point on end-points Source: Eur Respir Rev 2011; 20: 195-200 Year: 2011 Correlation of composite physiologic index with 6-minute walk test variables in patients with idiopathic interstitial pneumonias Source: International Congress 2016 – Clinical exercise physiology in health and disease Year: 2016 Neuropeptides and the pulmonary vasculature Source: Annual Congress 2006 - Neurogenic inflammation – the link between nervous system and lung dysfunction Year: 2006 Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension Source: Eur Respir J 2006; 27: 114-120 Year: 2006